BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23860016)

  • 1. Association of angiotensinogen gene polymorphisms and angiogenic factors with preeclampsia in Chinese women.
    Song C; Xie S; Wang J; Lian J; Diao B; Tang Y
    Gynecol Obstet Invest; 2013; 76(1):64-8. PubMed ID: 23860016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
    Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
    J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda.
    Nabweyambo S; Sande OJ; McGovern N; Bwanga F; Ssekagiri A; Keesiga A; Adroma M; Wasswa R; Atuheirwe M; Namugenyi J; Castelnuovo B; Nakimuli A
    PLoS One; 2021; 16(5):e0251227. PubMed ID: 34010327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
    Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
    Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
    Govender L; Mackraj I; Gathiram P; Moodley J
    Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
    PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.
    Akolekar R; de Cruz J; Foidart JM; Munaut C; Nicolaides KH
    Prenat Diagn; 2010 Mar; 30(3):191-7. PubMed ID: 20101671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
    Bdolah Y; Elchalal U; Natanson-Yaron S; Yechiam H; Bdolah-Abram T; Greenfield C; Goldman-Wohl D; Milwidsky A; Rana S; Karumanchi SA; Yagel S; Hochner-Celnikier D
    Hypertens Pregnancy; 2014 May; 33(2):250-9. PubMed ID: 24304210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
    Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study of M235T and A-6G polymorphisms in angiotensinogen gene with risk of developing preeclampsia in Iranian population.
    Alaee E; Mirahmadi M; Ghasemi M; Kashani E; Attar M; Shahbazi M
    Ann Hum Genet; 2019 Nov; 83(6):418-425. PubMed ID: 31090060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.